Back to Trades
Sell4
Jazz Pharmaceuticals plc
JAZZ
Total Value
$1.1M
Net $1.1M sold
Sales
$1.1M
3 transactions
Company Information
- Company Name
- Jazz Pharmaceuticals plc
- Ticker Symbol
- JAZZ
- CIK
- 0001232524
Insider Information
- Name
- COZADD BRUCE C
- Role
- Director
Director
Filing Details
- Filing Date
- Apr 3, 2026
- Transaction Date
- Apr 1, 2026
- Accession Number
- 0001193210-26-000009
- Form Type
- 4
- Net Trading Amount
- -$1.1M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Apr 1, 2026 | Ordinary Shares | 3,684 | $190.22 | Sale | $700.8K |
| Apr 1, 2026 | Ordinary Shares | 2,292 | $190.94 | Sale | $437.6K |
| Apr 1, 2026 | Ordinary Shares | 24 | $191.74 | Sale | $4.6K |
Footnotes
- (F1)This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person.
- (F2)Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $189.60 to $190.5603. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- (F3)Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $190.6051 to $190.5982. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.